Biblio Discovery — Demo Discovery Service

69 hasil untuk "Sarantis, Panagiotis"

Menampilkan 1–20 · 0,61 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Pregnane X Receptor (PXR) Polymorphisms and Cancer Treatment

    Skandalaki, Aikaterini; Sarantis, Panagiotis; Theocharis, Stamatios

    Biomolecules · 2021 · Inggris · PubMed Central

    Pregnane X Receptor (PXR) belongs to the nuclear receptors’ superfamily and mainly functions as a xenobiotic sensor activated by a variety of ligands. PXR is widely expressed in normal and malignant tissues. Drug metabolizing enzymes and transporters are also under PXR’s regulation. Antineoplastic…

  2. Artikel Jurnal Teks lengkap

    Upgraded role of autophagy in colorectal carcinomas

    Koustas, Evangelos; Sarantis, Panagiotis; Papavassiliou, Athanassios G dkk.

    World J Gastrointest Oncol · 2018 · Inggris · PubMed Central

    Autophagy is a basic catabolic process closely associated with degradation of cellular components. The role of autophagy in colorectal cancer (CRC) remains controversial. The mechanism of autophagy has been identified as protecting mechanism against tumorigenesis by isolation of damaged organelles…

  3. Artikel Jurnal Teks lengkap

    The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors

    Koustas, Evangelos; Sarantis, Panagiotis; Papavassiliou, Athanasios G. dkk.

    Biomolecules · 2020 · Inggris · PubMed Central

    The emergence of cancer immunotherapy has already shown some remarkable results, having changed the treatment strategy in clinical practice for solid tumors. Despite these promising long-term responses, patients seem to lack the ability to respond to immune checkpoint inhibitors, thus demonstrating…

  4. Artikel Jurnal Teks lengkap

    Pancreatic Cancer Prognosis, Malnutrition Risk, and Quality of Life: A Cross-Sectional Study

    Poulia, Kalliopi-Anna; Antoniadou, Dimitra; Sarantis, Panagiotis dkk.

    Nutrients · 2022 · Inggris · PubMed Central

    The present cross-sectional prospective study (from January 2017 until December 2020) aimed to evaluate the interrelation between nutritional parameters at the initial evaluation with the changes in QOL indicators and the Progression-Free Survival and Overall Survival in 97 patients with pancreatic…

  5. Artikel Jurnal Teks lengkap

    Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?

    Sarantis, Panagiotis; Koustas, Evangelos; Papavassiliou, Athanasios G. dkk.

    J Cell Mol Med · 2020 · Inggris · PubMed Central

    Undoubtedly, the new SARS‐CoV‐2 virus poses a grave health threat, plaguing the health and socio‐economic sectors. COVID‐19 disease must be treated quickly and effectively as soon as possible. The main axes in this direction are establishing vaccines, drugs, diagnostic tests, as well as identifying…

  6. Artikel Jurnal Teks lengkap

    The Controversial Role of Autophagy in Ewing Sarcoma Pathogenesis—Current Treatment Options

    Koustas, Evangelos; Sarantis, Panagiotis; Karamouzis, Michalis V. dkk.

    Biomolecules · 2021 · Inggris · PubMed Central

    Ewing Sarcoma (ES) is a rare, aggressive, and highly metastasizing cancer in children and young adults. Most ES cases carry the fusion of the Ewing Sarcoma Breakpoint Region 1 (EWSR1) and FLI1 (Friend leukemia virus integration site 1) genes, leading to an EWS–FLI1 fused protein, which is…

  7. Artikel Jurnal Teks lengkap

    The Interplay of Autophagy and Tumor Microenvironment in Colorectal Cancer—Ways of Enhancing Immunotherapy Action

    Koustas, Evangelos; Sarantis, Panagiotis; Kyriakopoulou, Georgia dkk.

    Cancers (Basel) · 2019 · Inggris · PubMed Central

    Autophagy as a primary homeostatic and catabolic process is responsible for the degradation and recycling of proteins and cellular components. The mechanism of autophagy has a crucial role in several cellular functions and its dysregulation is associated with tumorigenesis, tumor–stroma…

  8. Artikel Jurnal Teks lengkap

    Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy

    Sarantis, Panagiotis; Koustas, Evangelos; Papadimitropoulou, Adriana dkk.

    World J Gastrointest Oncol · 2020 · Inggris · PubMed Central

    Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal diseases, with an average 5-year survival rate of less than 10%. Unfortunately, the majority of patients have unresectable, locally advanced, or metastatic disease at the time of diagnosis. Moreover, traditional treatments such as…

  9. Artikel Jurnal Teks lengkap

    The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL

    Simatou, Aristofania; Sarantis, Panagiotis; Koustas, Evangelos dkk.

    Int J Mol Sci · 2020 · Inggris · PubMed Central

    The receptor activator of nuclear factor-κB (RANK) and the RANK ligand (RANKL) were reported in the regulation of osteoclast differentiation/activation and bone homeostasis. Additionally, the RANKL/RANK axis is a significant mediator of progesterone-driven mammary epithelial cell proliferation…

  10. Artikel Jurnal Teks lengkap

    Inhibition of c‐MET increases the antitumour activity of PARP inhibitors in gastric cancer models

    Koustas, Evangelos; Karamouzis, Michalis V.; Sarantis, Panagiotis dkk.

    J Cell Mol Med · 2020 · Inggris · PubMed Central

    Gastric cancer is the fifth most common malignancy and the third leading cause of cancer‐related death worldwide. Activation of c‐MET increases tumour cell survival through the initiation of the DNA damage repair pathway. PARP is an essential key in the DNA damage repair pathway. The primary role…

  11. Artikel Jurnal Teks lengkap

    Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy

    Koustas, Evangelos; Trifylli, Eleni-Myrto; Sarantis, Panagiotis dkk.

    World J Gastrointest Oncol · 2021 · Inggris · PubMed Central

    Cholangiocarcinomas (CCAs) are diverse biliary epithelial tumours involving the intrahepatic, perihilar and distal parts of the biliary tree. The three entirely variable entities have distinct epidemiology, molecular characteristics, prognosis and strategy for clinical management. However, many…

  12. Artikel Jurnal Teks lengkap

    Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas

    Bokas, Alexandros; Papakotoulas, Pavlos; Sarantis, Panagiotis dkk.

    Cancers (Basel) · 2020 · Inggris · PubMed Central

    Immune checkpoint inhibitors have revolutionized cancer treatment in the last decade. Despite the progress in immunotherapy, most pancreatic cancer patients still do not derive benefit when receiving immune-based therapies. Recently, resistance mechanisms to immune therapies have been mainly…

  13. Artikel Jurnal Teks lengkap

    Predictive Biomarkers for Immune-Related Endocrinopathies following Immune Checkpoint Inhibitors Treatment

    Shalit, Almog; Sarantis, Panagiotis; Koustas, Evangelos dkk.

    Cancers (Basel) · 2023 · Inggris · PubMed Central

    SIMPLE SUMMARY: In the last decade, immune checkpoint inhibitors have been incorporated into the array of oncologic treatments used in daily practice, leading to the improved prognosis of many cancers. With their widespread use, clinicians are increasingly confronted with a new category of adverse…

  14. Artikel Jurnal Teks lengkap

    Targeting autophagy in pancreatic cancer: The cancer stem cell perspective

    Troumpoukis, Dimitrios; Papadimitropoulou, Adriana; Charalampous, Chrysanthi dkk.

    Front Oncol · 2022 · Inggris · PubMed Central

    Pancreatic cancer is currently the seventh leading cause of cancer-related deaths worldwide, with the estimated death toll approaching half a million annually. Pancreatic ductal adenocarcinoma (PDAC) is the most common (>90% of cases) and most aggressive form of pancreatic cancer, with extremely…

  15. Artikel Jurnal Teks lengkap

    A Zebrafish In Vivo Phenotypic Assay to Identify 3-Aminothiophene-2-Carboxylic Acid-Based Angiogenesis Inhibitors

    Papakyriakou, Athanasios; Kefalos, Panagiotis; Sarantis, Panagiotis dkk.

    Assay Drug Dev Technol · 2014 · Inggris · PubMed Central

    Small molecules that inhibit angiogenesis are attractive drug candidates for cancer, retinopathies, and age-related macular degeneration. In vivo, phenotypic screening in zebrafish (Danio rerio) emerges as a powerful methodology to identify and optimize novel compounds with pharmacological…

  16. Artikel Jurnal Teks lengkap

    The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors

    Pouloudi, Despoina; Sotiriadis, Aristoteles; Theodorakidou, Margarita dkk.

    Int J Mol Sci · 2020 · Inggris · PubMed Central

    Salivary gland carcinomas (SGCs) represent a group of rare tumors, with complete surgical resection being the main treatment option. Therapeutic armory for cases of locally aggressive, recurrent, and/or metastatic SGCs, though, remains poor since they exhibit high rates of resistance to systematic…

  17. Artikel Jurnal Teks lengkap

    Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors

    Sarantis, Panagiotis; Trifylli, Eleni-Myrto; Koustas, Evangelos dkk.

    Int J Mol Sci · 2022 · Inggris · PubMed Central

    The development of cancer is a multifactorial phenomenon, while it constitutes a major global health problem. Viruses are an important factor that is involved in tumorigenesis and is associated with 12.1% of all cancer cases. Major examples of oncogenic viruses which are closely associated with the…

  18. Artikel Jurnal Teks lengkap

    Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules

    Vallilas, Christos; Sarantis, Panagiotis; Kyriazoglou, Anastasios dkk.

    Int J Mol Sci · 2021 · Inggris · PubMed Central

    Gastrointestinal stromal tumors (GISTs) are the most common types of malignant mesenchymal tumors in the gastrointestinal tract, with an estimated incidence of 1.5/100.000 per year and 1–2% of gastrointestinal neoplasms. About 75–80% of patients have mutations in the KIT gene in exons 9, 11, 13…

  19. Artikel Jurnal Teks lengkap

    The Role of p300 and TMPRSS2 in Prostate Cancer: Immunohistochemical Perspectives and Gleason Correlations

    GIOUKAKI, CHARITOMENI; GEORGIOU, ALEXANDROS; SARANTIS, PANAGIOTIS dkk.

    Cancer Diagn Progn · 2025 · Inggris · PubMed Central

    BACKGROUND/AIM: Transmembrane protease, serine 2 (TMPRSS2), and E1A-associated protein (p300) are important factors in prostate cancer (PCa) pathogenesis, playing significant roles in androgen receptor (AR) signaling and tumor progression. Despite their established role in PCa biology, their…